SCHEMBL4848201

SCHEMBL4848201

COc1ccc(C=CC(=O)c2cc(-c3ccccc3Cl)ccc2OCCN(C)C)c(OC)c1OC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.47
CHRNA7 P36544 1/20 0.46
ABCG2 Q9UNQ0 3/20 0.46
ALOX5 P09917 1/20 0.46
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MCL1 Q07820 2/20 0.43
CYP1A1 P04798 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP1B1 Q16678 2/20 0.42
CYP3A4 P08684 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853046 1.00 SLC6A9 (0.47) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4846127 0.93 CHRNA7 (0.48) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4845634 0.93 CHRNA7 (0.48) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4853325 0.91 CHRNA7 (0.51) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4850162 0.91 CHRNA7 (0.51) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4848206 0.91 MCL1 (0.50) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4845547 0.89 MCHR1 (0.49) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4853032 0.89 MCHR1 (0.49) SLC6A9CHRNA7ABCG2ALOX5NPC1
SCHEMBL4854239 0.87 SLC6A9 (0.46) SLC6A9ABCG2NPC1LMNASMN1; SMN2
SCHEMBL4848047 0.87 SLC6A9 (0.46) SLC6A9ABCG2NPC1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed